The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Engineering Tumors: A Tissue Engineering Perspective in Cancer Biology
Abstract
There is increasing recognition that three-dimensional (3D) tissue culture technologies have many uses within the biomedical sciences beyond the scope of regenerative medicine. One such use is in the field of cancer biology, where a 3D tumor model that accurately recreates the in vivo tumor phenotype would be a valuable tool for studying tumor biology and would allow better preclinical evaluation of anticancer drug candidates. The most widely used model involves small cellular aggregates, termed spheroids, which have been used by cancer biologists for decades and have consistently shown the superiority of 3D tissue culture over standard two-dimensional monolayer culture for mimicking the tumor behavior and drug resistance encountered in vivo. Currently, several research groups have begun to adapt more advanced 3D culture techniques from the tissue engineering field to create a more clinically accurate ex vivo model of tumor biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 2×
“93,94 97”
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.231 · Cited by 1,483 · cited 1×
“82 It was also shown that some signaling pathways that work independently when cells are cultured in 2D monolayers become reciprocally modulated upon transition to 3D growth.”
Three-dimensional culture models of normal and malignant breast epithelial cells
Lee, G. Y., Kenny, P. A., Lee, E. H., & Bissell, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1015 · Cited by 1,336
Recent advances in three‐dimensional multicellular spheroid culture for biomedical research
Lin, R., & Chang, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700228 · Cited by 1,264
Biomaterials in Tissue Engineering
Hubbell, J. A. (1995) · Nature Biotechnology · doi:10.1038/nbt0695-565 · Cited by 1,060
Kelland, L. R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.028 · Cited by 352 · cited 1×
“19,20,33 Because the 3D tumor microenvironment is of murine origin rather than human, subtle but important changes persist that impact tumor cell behavior, and these are exacerbated by the arti-ficial subcutaneous tumor localization.”
Generation of Multicellular Tumor Spheroids by the Hanging-Drop Method
Timmins, N. E., & Nielsen, L. K. (2007) · Methods in Molecular Medicine™ · doi:10.1007/978-1-59745-443-8_8 · Cited by 241 · cited 1×
“…To optimize experiments to ensure more consistent spheroid size and composition, recent adaptations involve spheroid formation within hanging drops 51 and microfluidic chips, 52 but these methods also require specialized equipment and additional handling steps that often outweigh any relative…”
Cited by
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
Day, C.-P., Merlino, G., & Van Dyke, T. (2015) · Cell · doi:10.1016/j.cell.2015.08.068 · Cited by 676
Advances in multicellular spheroids formation
Cui, X., Hartanto, Y., & Zhang, H. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2016.0877 · Cited by 508
3D Cell Culture in Alginate Hydrogels
Andersen, T., Auk-Emblem, P., & Dornish, M. (2015) · Microarrays · doi:10.3390/microarrays4020133 · Cited by 472
Afewerki, S., Sheikhi, A., Kannan, S., Ahadian, S., & Khademhosseini, A. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10124 · Cited by 409
Advanced Cell Culture Techniques for Cancer Drug Discovery
Lovitt, C., Shelper, T., & Avery, V. (2014) · Biology · doi:10.3390/biology3020345 · Cited by 282
3D tumor models: History, advances and future perspectives
Benien, P., & Swami, A. (2014) · Future Oncology · doi:10.2217/fon.13.274 · Cited by 208
Carey, S. P., Starchenko, A., McGregor, A. L., & Reinhart-King, C. A. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9565-x · Cited by 174
Optimization of liquid overlay technique to formulate heterogenic 3D co-cultures models
Costa, E. C., Gaspar, V. M., Coutinho, P., & Correia, I. J. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25210 · Cited by 156
Hydrogels to model 3D in vitro microenvironment of tumor vascularization
Song, H.-H. G., Park, K. M., & Gerecht, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.002 · Cited by 153
Extracellular Matrix Remodeling and Stiffening Modulate Tumor Phenotype and Treatment Response
Leight, J. L., Drain, A. P., & Weaver, V. M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-034431 · Cited by 131
Gioiella, F., Urciuolo, F., Imparato, G., Brancato, V., & Netti, P. A. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600772 · Cited by 112
Wen, Z., Liao, Q., Hu, Y., You, L., Zhou, L., & Zhao, Y. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132647 · Cited by 102
Deriving Primary Cancer Cell Cultures for Personalized Therapy
Esparza-López, J., Martínez-Aguilar, J. F., & Ibarra-Sánchez, M. D. J. (2019) · Revista de Investigación Clínica · doi:10.24875/ric.19002832 · Cited by 20
Metadata
- Authors
- Burdett, E., Kasper, F. K., Mikos, A. G., & Ludwig, J. A.
- Venue
- Tissue Engineering Part B: Reviews
- Publisher
- SAGE Publications
- Published
- 2010-06
- Volume
- 16
- Issue
- 3
- Pages
- 351-359
- ISSN
- 1937-3368 (ISSN-L)
- 1937-3376
- OpenAlex
- W2045810780
- Cited by
- 172
- References
- 10
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.